They also noted a reduction in KL-6, a molecule produced predominantly in the lung by damaged type II pneumocytes, but they did not evaluate the evolution of pulmonary fibrosis at HRCT (d’Alessandro et al. 2020). This evidence concerns the gene MUC1 and pulmonary fibrosis.